These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 30165035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
    Ma J, Weng L, Wang Z, Jia Y, Liu B, Wu S, Cao Y, Sun X, Yin X, Shang M, Mao A.
    Exp Cell Res; 2018 May 15; 366(2):103-113. PubMed ID: 29530475
    [Abstract] [Full Text] [Related]

  • 6. The Role of microRNAs in Cholangiocarcinoma.
    Shi T, Morishita A, Kobara H, Masaki T.
    Int J Mol Sci; 2021 Jul 16; 22(14):. PubMed ID: 34299246
    [Abstract] [Full Text] [Related]

  • 7. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, Thuwajit P, Thuwajit C, Kudo Y.
    Mol Cancer; 2018 Jan 18; 17(1):10. PubMed ID: 29347950
    [Abstract] [Full Text] [Related]

  • 8. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
    Shu L, Li X, Liu Z, Li K, Shi A, Tang Y, Zhao L, Huang L, Zhang Z, Zhang D, Huang S, Lian S, Sheng G, Yan Z, Zhang Z, Xu Y.
    Hepatology; 2024 Feb 01; 79(2):307-322. PubMed ID: 37140231
    [Abstract] [Full Text] [Related]

  • 9. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z, Ma J.
    Cancer Biomark; 2019 Feb 01; 24(2):173-181. PubMed ID: 30594918
    [Abstract] [Full Text] [Related]

  • 10. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Puik JR, Meijer LL, Le Large TY, Prado MM, Frampton AE, Kazemier G, Giovannetti E.
    Pharmacogenomics; 2017 Sep 01; 18(14):1343-1358. PubMed ID: 28832247
    [Abstract] [Full Text] [Related]

  • 11. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J, Sun L, Li J, Zhou C, Cheng L, Chen K, Yan B, Qian W, Ma Q, Duan W.
    Oncol Rep; 2018 Sep 01; 40(3):1422-1434. PubMed ID: 29956786
    [Abstract] [Full Text] [Related]

  • 12. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
    Loeffler MA, Hu J, Kirchner M, Wei X, Xiao Y, Albrecht T, De La Torre C, Sticht C, Banales JM, Vogel MN, Pathil-Warth A, Mehrabi A, Hoffmann K, Rupp C, Köhler B, Springfeld C, Schirmacher P, Ji J, Roessler S, Goeppert B.
    J Pathol; 2020 Nov 01; 252(3):239-251. PubMed ID: 32710569
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J.
    Mol Cancer; 2019 Mar 13; 18(1):40. PubMed ID: 30866952
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 13; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
    Lin KY, Ye H, Han BW, Wang WT, Wei PP, He B, Li XJ, Chen YQ.
    Oncogene; 2016 Jun 30; 35(26):3376-86. PubMed ID: 26455324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J, Gao B, Huang Z, Duan T, Li D, Zhang S, Zhao Y, Liu L, Wang Q, Chen Z, Cheng K.
    Int J Clin Exp Pathol; 2015 Jun 30; 8(8):9512-6. PubMed ID: 26464713
    [Abstract] [Full Text] [Related]

  • 20. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
    Okamoto K, Miyoshi K, Murawaki Y.
    PLoS One; 2013 Jun 30; 8(10):e77623. PubMed ID: 24147037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.